Suspension of trading

Financial Ratios AF2 CAPI

Stocks

AF.P

CA0010941015

Delayed Toronto S.E. 20:00:00 21/01/2026 +04			5-day change	1st Jan Change
0.0650 ^CAD	-.--%		-.--%	-

08-24	AF2 Capital Corp. has Changed its Name to Everkind Wellness Inc	CI
08-20	EverKind Inc completed the acquisition of AF2 Capital Corp. (TSXV:AF.P) in a reverse merger transaction.	CI

fea4f7a5aaefb8c68788faf04d.mSUlMlPqi_ZBPCZluMgI6D1if85N6x_5cXrcGXW16lA.7HdxQCaG-5FyeWEr8Jo6mw0AHo0piWaWSQ2UWELjp2XKdHRlOou5g3lSFg

Published financial data: AF2 CAPI

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: August	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	31.08K	14.31K	37.24K	12K	20.66K
Stock-Based Compensation (IS)	44.73K	-	-	-	-
Other Operating Expenses, Total	75.81K	14.31K	37.24K	12K	20.66K
Operating Income	-75.81K	-14.31K	-37.24K	-12K	-20.66K
Interest And Investment Income	-	-	5.04K	6.09K	3.98K
Net Interest Expenses	-	-	5.04K	6.09K	3.98K
Other Non Operating Income (Expenses)	-40.61K	-11.08K	-11.78K	-12.05K	-11.79K
EBT, Excl. Unusual Items	-116K	-25.39K	-43.98K	-17.96K	-28.47K
EBT, Incl. Unusual Items	-116K	-25.39K	-43.98K	-17.96K	-28.47K
Earnings From Continuing Operations	-116K	-25.39K	-43.98K	-17.96K	-28.47K
Net Income to Company	-116K	-25.39K	-43.98K	-17.96K	-28.47K
Net Income - (IS)	-116K	-25.39K	-43.98K	-17.96K	-28.47K
Net Income to Common Incl Extra Items	-116K	-25.39K	-43.98K	-17.96K	-28.47K
Net Income to Common Excl. Extra Items	-116K	-25.39K	-43.98K	-17.96K	-28.47K
Per Share Items
Net EPS - Basic	-0.08	-0.01	-0.01	-0.01	-0.01
Basic EPS - Continuing Operations	-0.08	-0.01	-0.01	-0.01	-0.01
Basic Weighted Average Shares Outstanding	1.39M	3M	3M	3M	3M
Net EPS - Diluted	-0.08	-0.01	-0.01	-0.01	-0.01
Diluted EPS - Continuing Operations	-0.08	-0.01	-0.01	-0.01	-0.01
Diluted Weighted Average Shares Outstanding	1.39M	3M	3M	3M	3M
Normalized Basic EPS	-0.05	-0.01	-0.01	-0	-0.01
Normalized Diluted EPS	-0.05	-0.01	-0.01	-0	-0.01
Supplemental Items
EBITA	-75.81K	-14.31K	-37.24K	-12K	-20.66K
EBIT	-75.81K	-14.31K	-37.24K	-12K	-20.66K
Normalized Net Income	-72.77K	-15.87K	-27.49K	-11.23K	-17.79K
Supplemental Operating Expense Items
General and Administrative Expenses	31.08K	14.31K	37.24K	12K	20.66K
Stock-Based Comp., Other (Total)	44.73K	-	-	-	-
Total Stock-Based Compensation	44.73K	-	-	-	-

Fiscal Period: August	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	250K	229K	196K	171K	149K
Total Cash And Short Term Investments	250K	229K	196K	171K	149K
Restricted Cash	-	-	-	-	-
Total Current Assets	250K	229K	196K	171K	149K
Total Assets	250K	229K	196K	171K	149K
Liabilities
Accounts Payable, Total	8.17K	13.46K	12.3K	11.41K	14.35K
Accrued Expenses, Total	-	-	11.53K	5.71K	9.27K
Total Current Liabilities	8.17K	13.46K	23.83K	17.11K	23.62K
Total Liabilities	8.17K	13.46K	23.83K	17.11K	23.62K
Common Stock, Total	322K	322K	322K	322K	322K
Additional Paid In Capital	60.39K	60.39K	60.39K	60.39K	60.39K
Retained Earnings	-141K	-167K	-211K	-229K	-257K
Total Common Equity	241K	216K	172K	154K	126K
Total Equity	241K	216K	172K	154K	126K
Total Liabilities And Equity	250K	229K	196K	171K	149K
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3M	3M	3M	3M	3M
ECS Total Common Shares Outstanding	3M	3M	3M	3M	3M
Book Value / Share	0.08	0.07	0.06	0.05	0.04
Tangible Book Value	241K	216K	172K	154K	126K
Tangible Book Value Per Share	0.08	0.07	0.06	0.05	0.04
Total Debt	0	0	0	0	0
Net Debt	-250K	-229K	-196K	-171K	-149K
Account Code - Inventory Valuation	3	-	3	3	3

Fiscal Period: August	2021	2022	2023	2024	2025
Net Income	-116K	-25.39K	-43.98K	-17.96K	-28.47K
Stock-Based Compensation (CF)	44.73K	-	-	-	-
Change In Accounts Payable	-16.83K	5.28K	10.37K	-6.71K	6.5K
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	-88.52K	-20.11K	-33.61K	-24.68K	-21.97K
Issuance of Common Stock	238K	-	-	-	-
Cash from Financing	238K	-	-	-	-
Net Change in Cash	150K	-20.11K	-33.61K	-24.68K	-21.97K
Supplemental Items
Levered Free Cash Flow	-19.48K	-3.66K	-12.91K	-14.22K	-6.41K
Unlevered Free Cash Flow	-19.48K	-3.66K	-12.91K	-14.22K	-6.41K
Change In Net Working Capital	16.83K	-5.28K	-10.37K	6.71K	-6.5K

Fiscal Period: August	2021	2022	2023	2024	2025
Profitability
Return on Assets	-27.11	-3.73	-10.95	-4.09	-8.06
Return on Total Capital	-29.96	-3.91	-12	-4.6	-9.24
Return On Equity %	-73.61	-11.11	-22.68	-11.02	-20.37
Return on Common Equity	-73.61	-11.11	-22.68	-11.02	-20.37
Short Term Liquidity
Current Ratio	30.53	17.05	8.22	10	6.31
Quick Ratio	30.53	17.05	8.22	10	6.31
Operating Cash Flow to Current Liabilities	-10.83	-1.49	-1.41	-1.44	-0.93
Long Term Solvency
Total Liabilities / Total Assets	3.28	5.87	12.17	10	15.84
Growth Over Prior Year
EBITA, 1 Yr. Growth %	-49.46	-81.13	160.29	-67.77	72.11
EBIT, 1 Yr. Growth %	-49.46	-81.13	160.29	-67.77	72.11
Earnings From Cont. Operations, 1 Yr. Growth %	-22.38	-78.19	73.22	-59.15	58.47
Net Income, 1 Yr. Growth %	-22.38	-78.19	73.22	-59.15	58.47
Normalized Net Income, 1 Yr. Growth %	-22.38	-78.19	73.22	-59.15	58.47
Diluted EPS Before Extra, 1 Yr. Growth %	-	-89.9	73.22	-59.15	58.47
Total Assets, 1 Yr. Growth %	149.5	-8.06	-14.65	-12.6	-12.84
Tangible Book Value, 1 Yr. Growth %	221.77	-10.52	-20.37	-10.45	-18.49
Common Equity, 1 Yr. Growth %	221.77	-10.52	-20.37	-10.45	-18.49
Cash From Operations, 1 Yr. Growth %	-	-77.29	67.15	-26.57	-10.99
Levered Free Cash Flow, 1 Yr. Growth %	-	-81.21	252.62	10.15	-54.9
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-81.21	252.62	10.15	-54.9
Compound Annual Growth Rate Over Two Years
EBITA, 2 Yr. CAGR %	-	-69.12	-29.91	-8.4	-25.52
EBIT, 2 Yr. CAGR %	-	-69.12	-29.91	-8.4	-25.52
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-58.86	-38.54	-15.88	-19.54
Net Income, 2 Yr. CAGR %	-	-58.86	-38.54	-15.88	-19.54
Normalized Net Income, 2 Yr. CAGR %	-	-58.86	-38.54	-15.88	-19.54
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-58.18	-15.88	-19.55
Total Assets, 2 Yr. CAGR %	-	51.46	-11.42	-13.63	-12.72
Tangible Book Value, 2 Yr. CAGR %	-	69.68	-15.59	-15.55	-14.56
Common Equity, 2 Yr. CAGR %	-	69.68	-15.59	-15.55	-14.56
Cash From Operations, 2 Yr. CAGR %	-	-	-38.38	10.79	-19.16
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-18.6	97.08	-29.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-18.6	97.08	-29.52
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	-	-	-37.15	-45.9	13.03
EBIT, 3 Yr. CAGR %	-	-	-37.15	-45.9	13.03
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-33.57	-46.36	3.89
Net Income, 3 Yr. CAGR %	-	-	-33.57	-46.36	3.89
Normalized Net Income, 3 Yr. CAGR %	-	-	-33.57	-46.36	3.89
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-58.51	3.89
Total Assets, 3 Yr. CAGR %	-	-	25.1	-11.81	-13.37
Tangible Book Value, 3 Yr. CAGR %	-	-	31.86	-13.91	-16.54
Common Equity, 3 Yr. CAGR %	-	-	31.86	-13.91	-16.54
Cash From Operations, 3 Yr. CAGR %	-	-	-	-34.67	2.99
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-9.97	20.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-9.97	20.54
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	-	-	-32.73
EBIT, 5 Yr. CAGR %	-	-	-	-	-32.73
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-28.28
Net Income, 5 Yr. CAGR %	-	-	-	-	-28.28
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-28.28
Total Assets, 5 Yr. CAGR %	-	-	-	-	8.32
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	10.85
Common Equity, 5 Yr. CAGR %	-	-	-	-	10.85